nodes	percent_of_prediction	percent_of_DWPC	metapath
Tenofovir—ABCC2—esophageal cancer	0.434	1	CbGaD
Tenofovir—ABCC10—Methotrexate—esophageal cancer	0.12	0.31	CbGbCtD
Tenofovir—ABCC2—Carboplatin—esophageal cancer	0.0619	0.159	CbGbCtD
Tenofovir—ABCC4—Methotrexate—esophageal cancer	0.0577	0.149	CbGbCtD
Tenofovir—ABCC2—Cisplatin—esophageal cancer	0.0529	0.136	CbGbCtD
Tenofovir—SLC22A8—Methotrexate—esophageal cancer	0.0361	0.0929	CbGbCtD
Tenofovir—ABCC2—Methotrexate—esophageal cancer	0.0343	0.0885	CbGbCtD
Tenofovir—SLC22A6—Methotrexate—esophageal cancer	0.0251	0.0647	CbGbCtD
Tenofovir—Cidofovir—TYMP—esophageal cancer	0.0057	0.811	CrCbGaD
Tenofovir—Renal tubular disorder—Cisplatin—esophageal cancer	0.0052	0.0988	CcSEcCtD
Tenofovir—NME1—neck—esophageal cancer	0.0039	0.091	CbGeAlD
Tenofovir—AK4—bronchus—esophageal cancer	0.00252	0.0587	CbGeAlD
Tenofovir—NME2—epithelium—esophageal cancer	0.0025	0.0583	CbGeAlD
Tenofovir—NME2—bronchus—esophageal cancer	0.00246	0.0574	CbGeAlD
Tenofovir—AK4—trachea—esophageal cancer	0.00226	0.0527	CbGeAlD
Tenofovir—AK2—lung—esophageal cancer	0.0022	0.0512	CbGeAlD
Tenofovir—NME1—digestive system—esophageal cancer	0.00202	0.0471	CbGeAlD
Tenofovir—NME1-NME2—lymph node—esophageal cancer	0.00198	0.0462	CbGeAlD
Tenofovir—AK4—digestive system—esophageal cancer	0.00195	0.0454	CbGeAlD
Tenofovir—NME2—digestive system—esophageal cancer	0.0019	0.0444	CbGeAlD
Tenofovir—Hepatic steatosis—Capecitabine—esophageal cancer	0.00184	0.035	CcSEcCtD
Tenofovir—NME1—lung—esophageal cancer	0.00169	0.0393	CbGeAlD
Tenofovir—AK4—lung—esophageal cancer	0.00163	0.0379	CbGeAlD
Tenofovir—NME2—lung—esophageal cancer	0.00159	0.037	CbGeAlD
Tenofovir—Amylase increased—Cisplatin—esophageal cancer	0.00159	0.0301	CcSEcCtD
Tenofovir—AK2—lymph node—esophageal cancer	0.0015	0.035	CbGeAlD
Tenofovir—Hypophosphataemia—Cisplatin—esophageal cancer	0.0013	0.0247	CcSEcCtD
Tenofovir—Serum creatinine increased—Cisplatin—esophageal cancer	0.00123	0.0233	CcSEcCtD
Tenofovir—ABCC10—bronchus—esophageal cancer	0.0012	0.0279	CbGeAlD
Tenofovir—NME1—lymph node—esophageal cancer	0.00115	0.0269	CbGeAlD
Tenofovir—AK4—lymph node—esophageal cancer	0.00111	0.0259	CbGeAlD
Tenofovir—NME2—lymph node—esophageal cancer	0.00109	0.0253	CbGeAlD
Tenofovir—ABCC10—trachea—esophageal cancer	0.00107	0.025	CbGeAlD
Tenofovir—ABCC4—bronchus—esophageal cancer	0.000992	0.0231	CbGeAlD
Tenofovir—ABCC10—digestive system—esophageal cancer	0.000924	0.0215	CbGeAlD
Tenofovir—Serum creatinine increased—Capecitabine—esophageal cancer	0.000905	0.0172	CcSEcCtD
Tenofovir—Hepatomegaly—Capecitabine—esophageal cancer	0.000786	0.0149	CcSEcCtD
Tenofovir—Pain—Carboplatin—esophageal cancer	0.000785	0.0149	CcSEcCtD
Tenofovir—ABCC10—lung—esophageal cancer	0.000772	0.018	CbGeAlD
Tenofovir—ABCC4—digestive system—esophageal cancer	0.000767	0.0179	CbGeAlD
Tenofovir—ABCC2—digestive system—esophageal cancer	0.000742	0.0173	CbGeAlD
Tenofovir—Body temperature increased—Carboplatin—esophageal cancer	0.000726	0.0138	CcSEcCtD
Tenofovir—Fracture—Methotrexate—esophageal cancer	0.000713	0.0135	CcSEcCtD
Tenofovir—Multiple fractures—Methotrexate—esophageal cancer	0.000713	0.0135	CcSEcCtD
Tenofovir—ABCC4—lung—esophageal cancer	0.00064	0.0149	CbGeAlD
Tenofovir—Proteinuria—Capecitabine—esophageal cancer	0.000634	0.012	CcSEcCtD
Tenofovir—Protein urine present—Capecitabine—esophageal cancer	0.000625	0.0119	CcSEcCtD
Tenofovir—Polyuria—Cisplatin—esophageal cancer	0.000624	0.0119	CcSEcCtD
Tenofovir—Renal failure acute—Cisplatin—esophageal cancer	0.000594	0.0113	CcSEcCtD
Tenofovir—Bone pain—Capecitabine—esophageal cancer	0.000581	0.011	CcSEcCtD
Tenofovir—Adenosine monophosphate—PDE4D—esophageal cancer	0.00055	0.0782	CrCbGaD
Tenofovir—ABCC10—lymph node—esophageal cancer	0.000528	0.0123	CbGeAlD
Tenofovir—CYP1A2—digestive system—esophageal cancer	0.000521	0.0121	CbGeAlD
Tenofovir—Blood creatinine increased—Cisplatin—esophageal cancer	0.000514	0.00975	CcSEcCtD
Tenofovir—Urine output increased—Capecitabine—esophageal cancer	0.000503	0.00955	CcSEcCtD
Tenofovir—Hypokalaemia—Cisplatin—esophageal cancer	0.000499	0.00947	CcSEcCtD
Tenofovir—Nasopharyngitis—Cisplatin—esophageal cancer	0.00049	0.00931	CcSEcCtD
Tenofovir—Proteinuria—Methotrexate—esophageal cancer	0.000472	0.00895	CcSEcCtD
Tenofovir—Protein urine present—Methotrexate—esophageal cancer	0.000465	0.00883	CcSEcCtD
Tenofovir—Pancreatitis—Cisplatin—esophageal cancer	0.000465	0.00882	CcSEcCtD
Tenofovir—Adenosine triphosphate—ABL1—esophageal cancer	0.00046	0.0655	CrCbGaD
Tenofovir—Polyuria—Capecitabine—esophageal cancer	0.00046	0.00874	CcSEcCtD
Tenofovir—ABCC4—lymph node—esophageal cancer	0.000438	0.0102	CbGeAlD
Tenofovir—Renal failure acute—Capecitabine—esophageal cancer	0.000438	0.00831	CcSEcCtD
Tenofovir—CYP1A2—lung—esophageal cancer	0.000435	0.0101	CbGeAlD
Tenofovir—Renal impairment—Capecitabine—esophageal cancer	0.000425	0.00806	CcSEcCtD
Tenofovir—ABCC2—lymph node—esophageal cancer	0.000424	0.00987	CbGeAlD
Tenofovir—Renal failure—Cisplatin—esophageal cancer	0.000415	0.00788	CcSEcCtD
Tenofovir—Neuropathy peripheral—Cisplatin—esophageal cancer	0.000414	0.00786	CcSEcCtD
Tenofovir—Hepatobiliary disease—Cisplatin—esophageal cancer	0.0004	0.00758	CcSEcCtD
Tenofovir—Blood creatinine increased—Capecitabine—esophageal cancer	0.000379	0.00719	CcSEcCtD
Tenofovir—Urine output increased—Methotrexate—esophageal cancer	0.000375	0.00711	CcSEcCtD
Tenofovir—Urinary tract disorder—Cisplatin—esophageal cancer	0.000375	0.00711	CcSEcCtD
Tenofovir—Connective tissue disorder—Cisplatin—esophageal cancer	0.000373	0.00707	CcSEcCtD
Tenofovir—Urethral disorder—Cisplatin—esophageal cancer	0.000372	0.00706	CcSEcCtD
Tenofovir—Hypokalaemia—Capecitabine—esophageal cancer	0.000368	0.00698	CcSEcCtD
Tenofovir—Nasopharyngitis—Capecitabine—esophageal cancer	0.000361	0.00686	CcSEcCtD
Tenofovir—Muscular weakness—Capecitabine—esophageal cancer	0.000356	0.00677	CcSEcCtD
Tenofovir—Polyuria—Methotrexate—esophageal cancer	0.000343	0.0065	CcSEcCtD
Tenofovir—Immune system disorder—Cisplatin—esophageal cancer	0.000343	0.0065	CcSEcCtD
Tenofovir—Mediastinal disorder—Cisplatin—esophageal cancer	0.000342	0.00649	CcSEcCtD
Tenofovir—Malnutrition—Cisplatin—esophageal cancer	0.00033	0.00627	CcSEcCtD
Tenofovir—Renal failure acute—Methotrexate—esophageal cancer	0.000326	0.00619	CcSEcCtD
Tenofovir—Flatulence—Cisplatin—esophageal cancer	0.000325	0.00618	CcSEcCtD
Tenofovir—Upper respiratory tract infection—Capecitabine—esophageal cancer	0.000325	0.00616	CcSEcCtD
Tenofovir—Weight decreased—Capecitabine—esophageal cancer	0.000316	0.006	CcSEcCtD
Tenofovir—Hyperglycaemia—Capecitabine—esophageal cancer	0.000315	0.00598	CcSEcCtD
Tenofovir—Pneumonia—Capecitabine—esophageal cancer	0.000313	0.00595	CcSEcCtD
Tenofovir—Infestation NOS—Capecitabine—esophageal cancer	0.000311	0.00591	CcSEcCtD
Tenofovir—Infestation—Capecitabine—esophageal cancer	0.000311	0.00591	CcSEcCtD
Tenofovir—Depression—Capecitabine—esophageal cancer	0.000311	0.00589	CcSEcCtD
Tenofovir—Renal failure—Capecitabine—esophageal cancer	0.000306	0.00581	CcSEcCtD
Tenofovir—Neuropathy peripheral—Capecitabine—esophageal cancer	0.000305	0.00579	CcSEcCtD
Tenofovir—Haematuria—Capecitabine—esophageal cancer	0.000297	0.00564	CcSEcCtD
Tenofovir—Hepatobiliary disease—Capecitabine—esophageal cancer	0.000295	0.00559	CcSEcCtD
Tenofovir—Myalgia—Cisplatin—esophageal cancer	0.000281	0.00534	CcSEcCtD
Tenofovir—Anxiety—Cisplatin—esophageal cancer	0.00028	0.00532	CcSEcCtD
Tenofovir—Hepatitis—Capecitabine—esophageal cancer	0.00028	0.00531	CcSEcCtD
Tenofovir—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	0.000279	0.0053	CcSEcCtD
Tenofovir—Urinary tract disorder—Capecitabine—esophageal cancer	0.000276	0.00524	CcSEcCtD
Tenofovir—Connective tissue disorder—Capecitabine—esophageal cancer	0.000275	0.00521	CcSEcCtD
Tenofovir—Urethral disorder—Capecitabine—esophageal cancer	0.000274	0.0052	CcSEcCtD
Tenofovir—Nervous system disorder—Cisplatin—esophageal cancer	0.000264	0.00502	CcSEcCtD
Tenofovir—Skin disorder—Cisplatin—esophageal cancer	0.000262	0.00497	CcSEcCtD
Tenofovir—Hyperhidrosis—Cisplatin—esophageal cancer	0.00026	0.00494	CcSEcCtD
Tenofovir—Anorexia—Cisplatin—esophageal cancer	0.000257	0.00488	CcSEcCtD
Tenofovir—Pancreatitis—Methotrexate—esophageal cancer	0.000255	0.00484	CcSEcCtD
Tenofovir—Immune system disorder—Capecitabine—esophageal cancer	0.000253	0.00479	CcSEcCtD
Tenofovir—Mediastinal disorder—Capecitabine—esophageal cancer	0.000252	0.00478	CcSEcCtD
Tenofovir—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.000245	0.00466	CcSEcCtD
Tenofovir—Mental disorder—Capecitabine—esophageal cancer	0.000245	0.00465	CcSEcCtD
Tenofovir—Malnutrition—Capecitabine—esophageal cancer	0.000243	0.00462	CcSEcCtD
Tenofovir—Upper respiratory tract infection—Methotrexate—esophageal cancer	0.000242	0.00459	CcSEcCtD
Tenofovir—Dyspnoea—Cisplatin—esophageal cancer	0.00024	0.00456	CcSEcCtD
Tenofovir—Flatulence—Capecitabine—esophageal cancer	0.00024	0.00455	CcSEcCtD
Tenofovir—Back pain—Capecitabine—esophageal cancer	0.000235	0.00447	CcSEcCtD
Tenofovir—Decreased appetite—Cisplatin—esophageal cancer	0.000234	0.00445	CcSEcCtD
Tenofovir—Pneumonia—Methotrexate—esophageal cancer	0.000233	0.00443	CcSEcCtD
Tenofovir—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.000233	0.00442	CcSEcCtD
Tenofovir—Infestation—Methotrexate—esophageal cancer	0.000232	0.0044	CcSEcCtD
Tenofovir—Infestation NOS—Methotrexate—esophageal cancer	0.000232	0.0044	CcSEcCtD
Tenofovir—Adenosine triphosphate—ABCC2—esophageal cancer	0.000231	0.0329	CrCbGaD
Tenofovir—Depression—Methotrexate—esophageal cancer	0.000231	0.00439	CcSEcCtD
Tenofovir—Pain—Cisplatin—esophageal cancer	0.00023	0.00437	CcSEcCtD
Tenofovir—Renal failure—Methotrexate—esophageal cancer	0.000228	0.00433	CcSEcCtD
Tenofovir—Sweating—Methotrexate—esophageal cancer	0.000222	0.00422	CcSEcCtD
Tenofovir—Haematuria—Methotrexate—esophageal cancer	0.000221	0.0042	CcSEcCtD
Tenofovir—Hepatobiliary disease—Methotrexate—esophageal cancer	0.000219	0.00416	CcSEcCtD
Tenofovir—Body temperature increased—Cisplatin—esophageal cancer	0.000213	0.00404	CcSEcCtD
Tenofovir—Hepatitis—Methotrexate—esophageal cancer	0.000208	0.00395	CcSEcCtD
Tenofovir—Arthralgia—Capecitabine—esophageal cancer	0.000207	0.00393	CcSEcCtD
Tenofovir—Chest pain—Capecitabine—esophageal cancer	0.000207	0.00393	CcSEcCtD
Tenofovir—Myalgia—Capecitabine—esophageal cancer	0.000207	0.00393	CcSEcCtD
Tenofovir—Anxiety—Capecitabine—esophageal cancer	0.000206	0.00392	CcSEcCtD
Tenofovir—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	0.000206	0.00391	CcSEcCtD
Tenofovir—Urinary tract disorder—Methotrexate—esophageal cancer	0.000206	0.0039	CcSEcCtD
Tenofovir—Urethral disorder—Methotrexate—esophageal cancer	0.000204	0.00387	CcSEcCtD
Tenofovir—Hypersensitivity—Cisplatin—esophageal cancer	0.000199	0.00377	CcSEcCtD
Tenofovir—Nervous system disorder—Capecitabine—esophageal cancer	0.000195	0.0037	CcSEcCtD
Tenofovir—Asthenia—Cisplatin—esophageal cancer	0.000193	0.00367	CcSEcCtD
Tenofovir—Skin disorder—Capecitabine—esophageal cancer	0.000193	0.00366	CcSEcCtD
Tenofovir—Hyperhidrosis—Capecitabine—esophageal cancer	0.000192	0.00364	CcSEcCtD
Tenofovir—Anorexia—Capecitabine—esophageal cancer	0.000189	0.00359	CcSEcCtD
Tenofovir—Immune system disorder—Methotrexate—esophageal cancer	0.000188	0.00357	CcSEcCtD
Tenofovir—Mediastinal disorder—Methotrexate—esophageal cancer	0.000188	0.00356	CcSEcCtD
Tenofovir—Diarrhoea—Cisplatin—esophageal cancer	0.000184	0.0035	CcSEcCtD
Tenofovir—Mental disorder—Methotrexate—esophageal cancer	0.000182	0.00346	CcSEcCtD
Tenofovir—Malnutrition—Methotrexate—esophageal cancer	0.000181	0.00344	CcSEcCtD
Tenofovir—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.000181	0.00343	CcSEcCtD
Tenofovir—Insomnia—Capecitabine—esophageal cancer	0.00018	0.00341	CcSEcCtD
Tenofovir—Dyspnoea—Capecitabine—esophageal cancer	0.000177	0.00336	CcSEcCtD
Tenofovir—Back pain—Methotrexate—esophageal cancer	0.000175	0.00333	CcSEcCtD
Tenofovir—Dyspepsia—Capecitabine—esophageal cancer	0.000175	0.00332	CcSEcCtD
Tenofovir—Decreased appetite—Capecitabine—esophageal cancer	0.000173	0.00328	CcSEcCtD
Tenofovir—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.000171	0.00325	CcSEcCtD
Tenofovir—Vomiting—Cisplatin—esophageal cancer	0.000171	0.00325	CcSEcCtD
Tenofovir—Fatigue—Capecitabine—esophageal cancer	0.000171	0.00325	CcSEcCtD
Tenofovir—Rash—Cisplatin—esophageal cancer	0.00017	0.00322	CcSEcCtD
Tenofovir—Pain—Capecitabine—esophageal cancer	0.00017	0.00322	CcSEcCtD
Tenofovir—Dermatitis—Cisplatin—esophageal cancer	0.00017	0.00322	CcSEcCtD
Tenofovir—Gastrointestinal pain—Capecitabine—esophageal cancer	0.000162	0.00308	CcSEcCtD
Tenofovir—Nausea—Cisplatin—esophageal cancer	0.00016	0.00304	CcSEcCtD
Tenofovir—Abdominal pain—Capecitabine—esophageal cancer	0.000157	0.00298	CcSEcCtD
Tenofovir—Body temperature increased—Capecitabine—esophageal cancer	0.000157	0.00298	CcSEcCtD
Tenofovir—Arthralgia—Methotrexate—esophageal cancer	0.000154	0.00293	CcSEcCtD
Tenofovir—Chest pain—Methotrexate—esophageal cancer	0.000154	0.00293	CcSEcCtD
Tenofovir—Myalgia—Methotrexate—esophageal cancer	0.000154	0.00293	CcSEcCtD
Tenofovir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	0.000153	0.00291	CcSEcCtD
Tenofovir—NME2—Metabolism—PLCE1—esophageal cancer	0.000152	0.00201	CbGpPWpGaD
Tenofovir—SLC22A6—SLC-mediated transmembrane transport—SLC30A7—esophageal cancer	0.000151	0.002	CbGpPWpGaD
Tenofovir—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP26A1—esophageal cancer	0.000151	0.002	CbGpPWpGaD
Tenofovir—CYP1A2—Phase 1 - Functionalization of compounds—ADH7—esophageal cancer	0.00015	0.00199	CbGpPWpGaD
Tenofovir—CYP1A2—Oxidation by Cytochrome P450—CYP26A1—esophageal cancer	0.000149	0.00197	CbGpPWpGaD
Tenofovir—Hypersensitivity—Capecitabine—esophageal cancer	0.000146	0.00278	CcSEcCtD
Tenofovir—Nervous system disorder—Methotrexate—esophageal cancer	0.000145	0.00275	CcSEcCtD
Tenofovir—AK2—Metabolism—GNG7—esophageal cancer	0.000145	0.00191	CbGpPWpGaD
Tenofovir—ABCC4—Platelet activation, signaling and aggregation—CFL1—esophageal cancer	0.000144	0.00191	CbGpPWpGaD
Tenofovir—Skin disorder—Methotrexate—esophageal cancer	0.000144	0.00273	CcSEcCtD
Tenofovir—Hyperhidrosis—Methotrexate—esophageal cancer	0.000143	0.00271	CcSEcCtD
Tenofovir—Asthenia—Capecitabine—esophageal cancer	0.000142	0.00271	CcSEcCtD
Tenofovir—CYP1A2—Tryptophan metabolism—ALDH2—esophageal cancer	0.000142	0.00188	CbGpPWpGaD
Tenofovir—ABCC2—NRF2 pathway—CYP2A6—esophageal cancer	0.000141	0.00186	CbGpPWpGaD
Tenofovir—Anorexia—Methotrexate—esophageal cancer	0.000141	0.00268	CcSEcCtD
Tenofovir—Pruritus—Capecitabine—esophageal cancer	0.000141	0.00267	CcSEcCtD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—BCL2—esophageal cancer	0.000138	0.00182	CbGpPWpGaD
Tenofovir—ABCC4—Platelet activation, signaling and aggregation—GNG7—esophageal cancer	0.000136	0.0018	CbGpPWpGaD
Tenofovir—Diarrhoea—Capecitabine—esophageal cancer	0.000136	0.00258	CcSEcCtD
Tenofovir—NME1—Metabolism—SLC10A2—esophageal cancer	0.000136	0.00179	CbGpPWpGaD
Tenofovir—NME1—Metabolism—CA1—esophageal cancer	0.000136	0.00179	CbGpPWpGaD
Tenofovir—AK2—Metabolism—ALDH2—esophageal cancer	0.000136	0.00179	CbGpPWpGaD
Tenofovir—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.000135	0.00256	CcSEcCtD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—ERBB2—esophageal cancer	0.000134	0.00177	CbGpPWpGaD
Tenofovir—Insomnia—Methotrexate—esophageal cancer	0.000134	0.00254	CcSEcCtD
Tenofovir—NME2—Metabolism—ADH1B—esophageal cancer	0.000133	0.00177	CbGpPWpGaD
Tenofovir—CYP1A2—Phase 1 - Functionalization of compounds—ADH1B—esophageal cancer	0.000132	0.00174	CbGpPWpGaD
Tenofovir—Dyspnoea—Methotrexate—esophageal cancer	0.000132	0.0025	CcSEcCtD
Tenofovir—Dizziness—Capecitabine—esophageal cancer	0.000131	0.00249	CcSEcCtD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—PTGS2—esophageal cancer	0.000131	0.00173	CbGpPWpGaD
Tenofovir—Dyspepsia—Methotrexate—esophageal cancer	0.00013	0.00247	CcSEcCtD
Tenofovir—AK2—Metabolism—GSTT1—esophageal cancer	0.000129	0.00171	CbGpPWpGaD
Tenofovir—Decreased appetite—Methotrexate—esophageal cancer	0.000129	0.00244	CcSEcCtD
Tenofovir—Gastrointestinal disorder—Methotrexate—esophageal cancer	0.000128	0.00242	CcSEcCtD
Tenofovir—AK2—Metabolism—CYP2A6—esophageal cancer	0.000128	0.00169	CbGpPWpGaD
Tenofovir—NME2—Metabolism—TYMP—esophageal cancer	0.000128	0.00169	CbGpPWpGaD
Tenofovir—Fatigue—Methotrexate—esophageal cancer	0.000127	0.00242	CcSEcCtD
Tenofovir—Pain—Methotrexate—esophageal cancer	0.000126	0.0024	CcSEcCtD
Tenofovir—Vomiting—Capecitabine—esophageal cancer	0.000126	0.0024	CcSEcCtD
Tenofovir—Rash—Capecitabine—esophageal cancer	0.000125	0.00238	CcSEcCtD
Tenofovir—Dermatitis—Capecitabine—esophageal cancer	0.000125	0.00237	CcSEcCtD
Tenofovir—Headache—Capecitabine—esophageal cancer	0.000124	0.00236	CcSEcCtD
Tenofovir—NME2—Metabolism—CYP26A1—esophageal cancer	0.000124	0.00164	CbGpPWpGaD
Tenofovir—NME1—Metabolism—CA2—esophageal cancer	0.000124	0.00164	CbGpPWpGaD
Tenofovir—CYP1A2—Phase 1 - Functionalization of compounds—CYP26A1—esophageal cancer	0.000123	0.00162	CbGpPWpGaD
Tenofovir—Gastrointestinal pain—Methotrexate—esophageal cancer	0.000121	0.0023	CcSEcCtD
Tenofovir—AK2—Metabolism—ENO1—esophageal cancer	0.000121	0.0016	CbGpPWpGaD
Tenofovir—AK2—Metabolism—PTGS1—esophageal cancer	0.000121	0.0016	CbGpPWpGaD
Tenofovir—NME2—Metabolism—ALOX15—esophageal cancer	0.000121	0.0016	CbGpPWpGaD
Tenofovir—AK2—Metabolism—PSME1—esophageal cancer	0.000119	0.00158	CbGpPWpGaD
Tenofovir—AK2—Metabolism—PSME2—esophageal cancer	0.000119	0.00158	CbGpPWpGaD
Tenofovir—ABCC4—Fluoropyrimidine Activity—TP53—esophageal cancer	0.000119	0.00157	CbGpPWpGaD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—CCND1—esophageal cancer	0.000118	0.00156	CbGpPWpGaD
Tenofovir—CYP1A2—Arachidonic acid metabolism—PTGS1—esophageal cancer	0.000118	0.00156	CbGpPWpGaD
Tenofovir—Nausea—Capecitabine—esophageal cancer	0.000118	0.00224	CcSEcCtD
Tenofovir—ABCC4—Hemostasis—ATP1B2—esophageal cancer	0.000118	0.00156	CbGpPWpGaD
Tenofovir—ABCC4—NRF2 pathway—TGFBR2—esophageal cancer	0.000117	0.00155	CbGpPWpGaD
Tenofovir—Body temperature increased—Methotrexate—esophageal cancer	0.000117	0.00222	CcSEcCtD
Tenofovir—Abdominal pain—Methotrexate—esophageal cancer	0.000117	0.00222	CcSEcCtD
Tenofovir—ABCC4—Ectoderm Differentiation—SMAD4—esophageal cancer	0.000116	0.00154	CbGpPWpGaD
Tenofovir—ABCC4—NRF2 pathway—HMOX1—esophageal cancer	0.000116	0.00153	CbGpPWpGaD
Tenofovir—NME2—Metabolism—TPI1—esophageal cancer	0.000115	0.00153	CbGpPWpGaD
Tenofovir—NME1—Metabolism—ADH7—esophageal cancer	0.000115	0.00153	CbGpPWpGaD
Tenofovir—NME1—Metabolism—PLCE1—esophageal cancer	0.000115	0.00153	CbGpPWpGaD
Tenofovir—NME2—Metabolism—GSTO1—esophageal cancer	0.000115	0.00153	CbGpPWpGaD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—CDKN1A—esophageal cancer	0.000114	0.00151	CbGpPWpGaD
Tenofovir—SLC22A8—Transmembrane transport of small molecules—SLC10A2—esophageal cancer	0.000113	0.0015	CbGpPWpGaD
Tenofovir—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—esophageal cancer	0.000113	0.00149	CbGpPWpGaD
Tenofovir—ABCC4—Platelet activation, signaling and aggregation—HSPA5—esophageal cancer	0.000111	0.00147	CbGpPWpGaD
Tenofovir—NME2—Metabolism—ALDOB—esophageal cancer	0.000111	0.00146	CbGpPWpGaD
Tenofovir—Hypersensitivity—Methotrexate—esophageal cancer	0.000109	0.00207	CcSEcCtD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—EP300—esophageal cancer	0.000109	0.00144	CbGpPWpGaD
Tenofovir—ABCC4—Transmembrane transport of small molecules—SLC10A2—esophageal cancer	0.000108	0.00143	CbGpPWpGaD
Tenofovir—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2A6—esophageal cancer	0.000108	0.00143	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor—CYP1B1—esophageal cancer	0.000107	0.00142	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1B1—esophageal cancer	0.000107	0.00142	CbGpPWpGaD
Tenofovir—CYP1A2—Tryptophan metabolism—CYP1B1—esophageal cancer	0.000107	0.00142	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—DOCK2—esophageal cancer	0.000106	0.00141	CbGpPWpGaD
Tenofovir—NME2—Metabolism—GAPDH—esophageal cancer	0.000106	0.00141	CbGpPWpGaD
Tenofovir—CYP1A2—Oxidation by Cytochrome P450—CYP2A6—esophageal cancer	0.000106	0.00141	CbGpPWpGaD
Tenofovir—SLC22A8—Transmembrane transport of small molecules—ATP1B2—esophageal cancer	0.000106	0.00141	CbGpPWpGaD
Tenofovir—Asthenia—Methotrexate—esophageal cancer	0.000106	0.00201	CcSEcCtD
Tenofovir—NME2—Metabolism—CRABP1—esophageal cancer	0.000105	0.0014	CbGpPWpGaD
Tenofovir—Pruritus—Methotrexate—esophageal cancer	0.000105	0.00199	CcSEcCtD
Tenofovir—CYP1A2—Phase II conjugation—GSTO1—esophageal cancer	0.000103	0.00137	CbGpPWpGaD
Tenofovir—AK2—Metabolism—CYP1B1—esophageal cancer	0.000103	0.00136	CbGpPWpGaD
Tenofovir—ABCC4—Transmembrane transport of small molecules—ATP1B2—esophageal cancer	0.000102	0.00135	CbGpPWpGaD
Tenofovir—ABCC10—Transmembrane transport of small molecules—HMOX1—esophageal cancer	0.000102	0.00135	CbGpPWpGaD
Tenofovir—Diarrhoea—Methotrexate—esophageal cancer	0.000101	0.00192	CcSEcCtD
Tenofovir—NME1—Metabolism—ADH1B—esophageal cancer	0.000101	0.00134	CbGpPWpGaD
Tenofovir—CYP1A2—Tryptophan metabolism—CYP19A1—esophageal cancer	0.000101	0.00134	CbGpPWpGaD
Tenofovir—SLC22A8—Transmembrane transport of small molecules—SLC39A6—esophageal cancer	0.000101	0.00133	CbGpPWpGaD
Tenofovir—CYP1A2—Arachidonic acid metabolism—CYP1B1—esophageal cancer	0.0001	0.00133	CbGpPWpGaD
Tenofovir—NME2—Metabolism—GNG7—esophageal cancer	0.0001	0.00133	CbGpPWpGaD
Tenofovir—ABCC2—NRF2 pathway—TGFBR2—esophageal cancer	9.88e-05	0.00131	CbGpPWpGaD
Tenofovir—Dizziness—Methotrexate—esophageal cancer	9.78e-05	0.00186	CcSEcCtD
Tenofovir—ABCC10—Transmembrane transport of small molecules—ABCB1—esophageal cancer	9.76e-05	0.00129	CbGpPWpGaD
Tenofovir—ABCC2—NRF2 pathway—HMOX1—esophageal cancer	9.75e-05	0.00129	CbGpPWpGaD
Tenofovir—AK2—Metabolism—CYP19A1—esophageal cancer	9.66e-05	0.00128	CbGpPWpGaD
Tenofovir—NME1—Metabolism—TYMP—esophageal cancer	9.66e-05	0.00128	CbGpPWpGaD
Tenofovir—ABCC4—Transmembrane transport of small molecules—SLC39A6—esophageal cancer	9.66e-05	0.00128	CbGpPWpGaD
Tenofovir—SLC22A8—Transmembrane transport of small molecules—AQP3—esophageal cancer	9.61e-05	0.00127	CbGpPWpGaD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—MYC—esophageal cancer	9.48e-05	0.00125	CbGpPWpGaD
Tenofovir—SLC22A6—Transmembrane transport of small molecules—SLC10A2—esophageal cancer	9.43e-05	0.00125	CbGpPWpGaD
Tenofovir—Vomiting—Methotrexate—esophageal cancer	9.4e-05	0.00178	CcSEcCtD
Tenofovir—NME2—Metabolism—ALDH2—esophageal cancer	9.4e-05	0.00124	CbGpPWpGaD
Tenofovir—NME1—Metabolism—CYP26A1—esophageal cancer	9.4e-05	0.00124	CbGpPWpGaD
Tenofovir—Rash—Methotrexate—esophageal cancer	9.32e-05	0.00177	CcSEcCtD
Tenofovir—Dermatitis—Methotrexate—esophageal cancer	9.31e-05	0.00177	CcSEcCtD
Tenofovir—CYP1A2—Phase 1 - Functionalization of compounds—ALDH2—esophageal cancer	9.29e-05	0.00123	CbGpPWpGaD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—EGFR—esophageal cancer	9.28e-05	0.00123	CbGpPWpGaD
Tenofovir—Headache—Methotrexate—esophageal cancer	9.26e-05	0.00176	CcSEcCtD
Tenofovir—ABCC4—Transmembrane transport of small molecules—AQP3—esophageal cancer	9.22e-05	0.00122	CbGpPWpGaD
Tenofovir—SLC22A8—Transmembrane transport of small molecules—ATP4A—esophageal cancer	9.22e-05	0.00122	CbGpPWpGaD
Tenofovir—SLC22A8—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	9.22e-05	0.00122	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—PFN1—esophageal cancer	9.19e-05	0.00122	CbGpPWpGaD
Tenofovir—NME1—Metabolism—ALOX15—esophageal cancer	9.16e-05	0.00121	CbGpPWpGaD
Tenofovir—ABCC2—Transmembrane transport of small molecules—SLC10A2—esophageal cancer	9.14e-05	0.00121	CbGpPWpGaD
Tenofovir—NME2—Metabolism—GSTT1—esophageal cancer	8.94e-05	0.00118	CbGpPWpGaD
Tenofovir—SLC22A6—Transmembrane transport of small molecules—ATP1B2—esophageal cancer	8.87e-05	0.00117	CbGpPWpGaD
Tenofovir—NME2—Metabolism—CYP2A6—esophageal cancer	8.84e-05	0.00117	CbGpPWpGaD
Tenofovir—ABCC4—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	8.84e-05	0.00117	CbGpPWpGaD
Tenofovir—ABCC4—Transmembrane transport of small molecules—ATP4A—esophageal cancer	8.84e-05	0.00117	CbGpPWpGaD
Tenofovir—AK2—Metabolism—HMOX1—esophageal cancer	8.82e-05	0.00117	CbGpPWpGaD
Tenofovir—Nausea—Methotrexate—esophageal cancer	8.78e-05	0.00167	CcSEcCtD
Tenofovir—NME1—Metabolism—TPI1—esophageal cancer	8.74e-05	0.00116	CbGpPWpGaD
Tenofovir—NME1—Metabolism—GSTO1—esophageal cancer	8.74e-05	0.00116	CbGpPWpGaD
Tenofovir—CYP1A2—Phase 1 - Functionalization of compounds—CYP2A6—esophageal cancer	8.74e-05	0.00116	CbGpPWpGaD
Tenofovir—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1B1—esophageal cancer	8.69e-05	0.00115	CbGpPWpGaD
Tenofovir—ABCC2—Transmembrane transport of small molecules—ATP1B2—esophageal cancer	8.59e-05	0.00114	CbGpPWpGaD
Tenofovir—CYP1A2—Oxidation by Cytochrome P450—CYP1B1—esophageal cancer	8.57e-05	0.00113	CbGpPWpGaD
Tenofovir—Adenosine triphosphate—ABCB1—esophageal cancer	8.51e-05	0.0121	CrCbGaD
Tenofovir—AK2—Metabolism—ABCB1—esophageal cancer	8.46e-05	0.00112	CbGpPWpGaD
Tenofovir—SLC22A6—Transmembrane transport of small molecules—SLC39A6—esophageal cancer	8.41e-05	0.00111	CbGpPWpGaD
Tenofovir—NME2—Metabolism—PTGS1—esophageal cancer	8.38e-05	0.00111	CbGpPWpGaD
Tenofovir—NME2—Metabolism—ENO1—esophageal cancer	8.38e-05	0.00111	CbGpPWpGaD
Tenofovir—NME1—Metabolism—ALDOB—esophageal cancer	8.38e-05	0.00111	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor Pathway—BAX—esophageal cancer	8.37e-05	0.00111	CbGpPWpGaD
Tenofovir—CYP1A2—Phase 1 - Functionalization of compounds—PTGS1—esophageal cancer	8.28e-05	0.0011	CbGpPWpGaD
Tenofovir—NME2—Metabolism—PSME1—esophageal cancer	8.26e-05	0.00109	CbGpPWpGaD
Tenofovir—NME2—Metabolism—PSME2—esophageal cancer	8.26e-05	0.00109	CbGpPWpGaD
Tenofovir—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP19A1—esophageal cancer	8.17e-05	0.00108	CbGpPWpGaD
Tenofovir—ABCC2—Transmembrane transport of small molecules—SLC39A6—esophageal cancer	8.15e-05	0.00108	CbGpPWpGaD
Tenofovir—NME1—Metabolism—GAPDH—esophageal cancer	8.07e-05	0.00107	CbGpPWpGaD
Tenofovir—CYP1A2—Oxidation by Cytochrome P450—CYP19A1—esophageal cancer	8.06e-05	0.00107	CbGpPWpGaD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—PIK3CA—esophageal cancer	8.05e-05	0.00107	CbGpPWpGaD
Tenofovir—CYP1A2—Phase II conjugation—GSTT1—esophageal cancer	8.02e-05	0.00106	CbGpPWpGaD
Tenofovir—SLC22A6—Transmembrane transport of small molecules—AQP3—esophageal cancer	8.02e-05	0.00106	CbGpPWpGaD
Tenofovir—NME1—Metabolism—CRABP1—esophageal cancer	7.99e-05	0.00106	CbGpPWpGaD
Tenofovir—CYP1A2—Biological oxidations—ADH7—esophageal cancer	7.99e-05	0.00106	CbGpPWpGaD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—TP53—esophageal cancer	7.79e-05	0.00103	CbGpPWpGaD
Tenofovir—ABCC2—Transmembrane transport of small molecules—AQP3—esophageal cancer	7.77e-05	0.00103	CbGpPWpGaD
Tenofovir—SLC22A6—Transmembrane transport of small molecules—ATP4A—esophageal cancer	7.69e-05	0.00102	CbGpPWpGaD
Tenofovir—SLC22A6—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	7.69e-05	0.00102	CbGpPWpGaD
Tenofovir—NME1—Metabolism—GNG7—esophageal cancer	7.6e-05	0.00101	CbGpPWpGaD
Tenofovir—ABCC2—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	7.45e-05	0.000986	CbGpPWpGaD
Tenofovir—ABCC2—Transmembrane transport of small molecules—ATP4A—esophageal cancer	7.45e-05	0.000986	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—CFL1—esophageal cancer	7.45e-05	0.000985	CbGpPWpGaD
Tenofovir—NME2—Metabolism—CYP1B1—esophageal cancer	7.12e-05	0.000943	CbGpPWpGaD
Tenofovir—NME1—Metabolism—ALDH2—esophageal cancer	7.12e-05	0.000943	CbGpPWpGaD
Tenofovir—CYP1A2—Phase 1 - Functionalization of compounds—CYP1B1—esophageal cancer	7.04e-05	0.000932	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—GNG7—esophageal cancer	7.02e-05	0.000929	CbGpPWpGaD
Tenofovir—CYP1A2—Biological oxidations—ADH1B—esophageal cancer	7e-05	0.000927	CbGpPWpGaD
Tenofovir—SLC22A8—Transmembrane transport of small molecules—ABCC2—esophageal cancer	6.98e-05	0.000924	CbGpPWpGaD
Tenofovir—NME1—Metabolism—GSTT1—esophageal cancer	6.78e-05	0.000897	CbGpPWpGaD
Tenofovir—NME2—Metabolism—CYP19A1—esophageal cancer	6.7e-05	0.000886	CbGpPWpGaD
Tenofovir—NME1—Metabolism—CYP2A6—esophageal cancer	6.7e-05	0.000886	CbGpPWpGaD
Tenofovir—ABCC4—Transmembrane transport of small molecules—ABCC2—esophageal cancer	6.7e-05	0.000886	CbGpPWpGaD
Tenofovir—CYP1A2—Phase 1 - Functionalization of compounds—CYP19A1—esophageal cancer	6.62e-05	0.000876	CbGpPWpGaD
Tenofovir—ABCC10—Transmembrane transport of small molecules—CREBBP—esophageal cancer	6.52e-05	0.000863	CbGpPWpGaD
Tenofovir—CYP1A2—Biological oxidations—CYP26A1—esophageal cancer	6.51e-05	0.000862	CbGpPWpGaD
Tenofovir—CYP1A2—Metapathway biotransformation—CYP26A1—esophageal cancer	6.42e-05	0.00085	CbGpPWpGaD
Tenofovir—NME1—Metabolism—ENO1—esophageal cancer	6.35e-05	0.00084	CbGpPWpGaD
Tenofovir—NME1—Metabolism—PTGS1—esophageal cancer	6.35e-05	0.00084	CbGpPWpGaD
Tenofovir—SLC22A8—Transmembrane transport of small molecules—GNG7—esophageal cancer	6.34e-05	0.000839	CbGpPWpGaD
Tenofovir—NME1—Metabolism—PSME1—esophageal cancer	6.26e-05	0.000828	CbGpPWpGaD
Tenofovir—NME1—Metabolism—PSME2—esophageal cancer	6.26e-05	0.000828	CbGpPWpGaD
Tenofovir—NME2—Metabolism—HMOX1—esophageal cancer	6.11e-05	0.000809	CbGpPWpGaD
Tenofovir—ABCC4—Transmembrane transport of small molecules—GNG7—esophageal cancer	6.08e-05	0.000804	CbGpPWpGaD
Tenofovir—CYP1A2—Biological oxidations—GSTO1—esophageal cancer	6.05e-05	0.000801	CbGpPWpGaD
Tenofovir—CYP1A2—Metapathway biotransformation—GSTO1—esophageal cancer	5.97e-05	0.00079	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor—RB1—esophageal cancer	5.89e-05	0.000779	CbGpPWpGaD
Tenofovir—NME2—Metabolism—ABCB1—esophageal cancer	5.87e-05	0.000776	CbGpPWpGaD
Tenofovir—SLC22A6—Transmembrane transport of small molecules—ABCC2—esophageal cancer	5.83e-05	0.000771	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—HSPA5—esophageal cancer	5.72e-05	0.000757	CbGpPWpGaD
Tenofovir—AK2—Metabolism—CREBBP—esophageal cancer	5.66e-05	0.000748	CbGpPWpGaD
Tenofovir—NME1—Metabolism—CYP1B1—esophageal cancer	5.4e-05	0.000714	CbGpPWpGaD
Tenofovir—SLC22A6—Transmembrane transport of small molecules—GNG7—esophageal cancer	5.29e-05	0.0007	CbGpPWpGaD
Tenofovir—ABCC2—Transmembrane transport of small molecules—GNG7—esophageal cancer	5.12e-05	0.000678	CbGpPWpGaD
Tenofovir—NME1—Metabolism—CYP19A1—esophageal cancer	5.08e-05	0.000672	CbGpPWpGaD
Tenofovir—AK2—Metabolism—NOS3—esophageal cancer	5.06e-05	0.00067	CbGpPWpGaD
Tenofovir—CYP1A2—Biological oxidations—ALDH2—esophageal cancer	4.94e-05	0.000653	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—esophageal cancer	4.84e-05	0.000641	CbGpPWpGaD
Tenofovir—CYP1A2—Biological oxidations—GSTT1—esophageal cancer	4.69e-05	0.000621	CbGpPWpGaD
Tenofovir—CYP1A2—Biological oxidations—CYP2A6—esophageal cancer	4.64e-05	0.000614	CbGpPWpGaD
Tenofovir—NME1—Metabolism—HMOX1—esophageal cancer	4.63e-05	0.000613	CbGpPWpGaD
Tenofovir—AK2—Metabolism—PTGS2—esophageal cancer	4.63e-05	0.000613	CbGpPWpGaD
Tenofovir—ABCC4—Ectoderm Differentiation—MYC—esophageal cancer	4.6e-05	0.000609	CbGpPWpGaD
Tenofovir—CYP1A2—Arachidonic acid metabolism—PTGS2—esophageal cancer	4.53e-05	0.000599	CbGpPWpGaD
Tenofovir—NME1—Metabolism—ABCB1—esophageal cancer	4.45e-05	0.000588	CbGpPWpGaD
Tenofovir—CYP1A2—Biological oxidations—PTGS1—esophageal cancer	4.4e-05	0.000582	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—ABL1—esophageal cancer	4.24e-05	0.000561	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—esophageal cancer	4.23e-05	0.00056	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—esophageal cancer	4.03e-05	0.000533	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor—EP300—esophageal cancer	4.03e-05	0.000533	CbGpPWpGaD
Tenofovir—NME2—Metabolism—CREBBP—esophageal cancer	3.92e-05	0.000519	CbGpPWpGaD
Tenofovir—SLC22A8—Transmembrane transport of small molecules—HMOX1—esophageal cancer	3.86e-05	0.000511	CbGpPWpGaD
Tenofovir—AK2—Metabolism—EP300—esophageal cancer	3.85e-05	0.00051	CbGpPWpGaD
Tenofovir—CYP1A2—Biological oxidations—CYP1B1—esophageal cancer	3.74e-05	0.000495	CbGpPWpGaD
Tenofovir—SLC22A8—Transmembrane transport of small molecules—ABCB1—esophageal cancer	3.71e-05	0.00049	CbGpPWpGaD
Tenofovir—ABCC4—Transmembrane transport of small molecules—HMOX1—esophageal cancer	3.7e-05	0.00049	CbGpPWpGaD
Tenofovir—CYP1A2—Metapathway biotransformation—CYP1B1—esophageal cancer	3.69e-05	0.000488	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—SLC10A2—esophageal cancer	3.61e-05	0.000477	CbGpPWpGaD
Tenofovir—ABCC4—Transmembrane transport of small molecules—ABCB1—esophageal cancer	3.55e-05	0.00047	CbGpPWpGaD
Tenofovir—CYP1A2—Biological oxidations—CYP19A1—esophageal cancer	3.52e-05	0.000465	CbGpPWpGaD
Tenofovir—NME2—Metabolism—NOS3—esophageal cancer	3.51e-05	0.000465	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor—MYC—esophageal cancer	3.51e-05	0.000464	CbGpPWpGaD
Tenofovir—CYP1A2—Metapathway biotransformation—CYP19A1—esophageal cancer	3.47e-05	0.000459	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—esophageal cancer	3.43e-05	0.000454	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—esophageal cancer	3.43e-05	0.000454	CbGpPWpGaD
Tenofovir—SLC22A6—Transmembrane transport of small molecules—HMOX1—esophageal cancer	3.22e-05	0.000426	CbGpPWpGaD
Tenofovir—NME2—Metabolism—PTGS2—esophageal cancer	3.21e-05	0.000425	CbGpPWpGaD
Tenofovir—ABCC2—Transmembrane transport of small molecules—HMOX1—esophageal cancer	3.12e-05	0.000413	CbGpPWpGaD
Tenofovir—SLC22A6—Transmembrane transport of small molecules—ABCB1—esophageal cancer	3.09e-05	0.000409	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—NOS2—esophageal cancer	3.06e-05	0.000404	CbGpPWpGaD
Tenofovir—ABCC2—Transmembrane transport of small molecules—ABCB1—esophageal cancer	3e-05	0.000396	CbGpPWpGaD
Tenofovir—NME1—Metabolism—CREBBP—esophageal cancer	2.97e-05	0.000393	CbGpPWpGaD
Tenofovir—AK2—Metabolism—PIK3CA—esophageal cancer	2.85e-05	0.000377	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—CREBBP—esophageal cancer	2.74e-05	0.000363	CbGpPWpGaD
Tenofovir—ABCC4—Platelet activation, signaling and aggregation—PIK3CA—esophageal cancer	2.68e-05	0.000355	CbGpPWpGaD
Tenofovir—NME2—Metabolism—EP300—esophageal cancer	2.67e-05	0.000353	CbGpPWpGaD
Tenofovir—NME1—Metabolism—NOS3—esophageal cancer	2.66e-05	0.000352	CbGpPWpGaD
Tenofovir—SLC22A8—Transmembrane transport of small molecules—CREBBP—esophageal cancer	2.48e-05	0.000328	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—NOS3—esophageal cancer	2.46e-05	0.000325	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—ALOX15—esophageal cancer	2.44e-05	0.000322	CbGpPWpGaD
Tenofovir—NME1—Metabolism—PTGS2—esophageal cancer	2.43e-05	0.000322	CbGpPWpGaD
Tenofovir—ABCC4—Transmembrane transport of small molecules—CREBBP—esophageal cancer	2.37e-05	0.000314	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	2.13e-05	0.000281	CbGpPWpGaD
Tenofovir—SLC22A6—Transmembrane transport of small molecules—CREBBP—esophageal cancer	2.07e-05	0.000274	CbGpPWpGaD
Tenofovir—NME1—Metabolism—EP300—esophageal cancer	2.02e-05	0.000268	CbGpPWpGaD
Tenofovir—ABCC2—Transmembrane transport of small molecules—CREBBP—esophageal cancer	2e-05	0.000265	CbGpPWpGaD
Tenofovir—NME2—Metabolism—PIK3CA—esophageal cancer	1.98e-05	0.000261	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—SLC52A3—esophageal cancer	1.89e-05	0.00025	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—BLVRB—esophageal cancer	1.89e-05	0.00025	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—EP300—esophageal cancer	1.87e-05	0.000247	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	1.69e-05	0.000224	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—CA1—esophageal cancer	1.61e-05	0.000213	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—SLC10A2—esophageal cancer	1.61e-05	0.000213	CbGpPWpGaD
Tenofovir—NME1—Metabolism—PIK3CA—esophageal cancer	1.5e-05	0.000198	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—CA2—esophageal cancer	1.47e-05	0.000194	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	1.44e-05	0.00019	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—PIK3CA—esophageal cancer	1.38e-05	0.000183	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—PLCE1—esophageal cancer	1.37e-05	0.000181	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—ADH7—esophageal cancer	1.37e-05	0.000181	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	1.35e-05	0.000179	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—TP53—esophageal cancer	1.34e-05	0.000177	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—ADH1B—esophageal cancer	1.2e-05	0.000159	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—TYMP—esophageal cancer	1.14e-05	0.000151	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—CYP26A1—esophageal cancer	1.11e-05	0.000147	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—ALOX15—esophageal cancer	1.09e-05	0.000144	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—GSTO1—esophageal cancer	1.04e-05	0.000137	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—TPI1—esophageal cancer	1.04e-05	0.000137	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—ALDOB—esophageal cancer	9.93e-06	0.000131	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—GAPDH—esophageal cancer	9.55e-06	0.000126	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—CRABP1—esophageal cancer	9.47e-06	0.000125	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—GNG7—esophageal cancer	9.01e-06	0.000119	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—ALDH2—esophageal cancer	8.44e-06	0.000112	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—GSTT1—esophageal cancer	8.03e-06	0.000106	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—CYP2A6—esophageal cancer	7.94e-06	0.000105	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	7.9e-06	0.000105	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—PTGS1—esophageal cancer	7.52e-06	9.95e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—ENO1—esophageal cancer	7.52e-06	9.95e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—PSME2—esophageal cancer	7.41e-06	9.81e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—PSME1—esophageal cancer	7.41e-06	9.81e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	6.47e-06	8.56e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—CYP1B1—esophageal cancer	6.4e-06	8.46e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—CYP19A1—esophageal cancer	6.01e-06	7.96e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—HMOX1—esophageal cancer	5.49e-06	7.26e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	5.38e-06	7.12e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—ABCB1—esophageal cancer	5.27e-06	6.97e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	3.98e-06	5.27e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—CREBBP—esophageal cancer	3.52e-06	4.66e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—NOS3—esophageal cancer	3.15e-06	4.17e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—PTGS2—esophageal cancer	2.88e-06	3.81e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—EP300—esophageal cancer	2.4e-06	3.17e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—PIK3CA—esophageal cancer	1.77e-06	2.35e-05	CbGpPWpGaD
